The Future of Point-of-Care (POC) Testing in Asia-Pacific (APAC)

Point-of-care (POC) diagnostics is expected to be one of the fastest-growing major in-vitro diagnostics (IVD) market segments in Asia-Pacific (APAC).
EIU Healthcare estimates the APAC POC diagnostics market to increase by 6.4% annually on average during the 2019-2024 forecast period.
This report highlights the decentralisation trend in testing, the regional solutions to improve healthcare access, and the growing role of POC testing in driving regional disease elimination and control goals. The report also offers deep insights into the rise of domestic IVD players amid the growing needs for POC testing.

Download the report to find out:

• How the Covid-19 pandemic is accelerating the decentralisation trend in testing and how POC testing is used as a key tool to manage healthcare capacity

• Which are the top three fastest-growing market segments in POC diagnostics (2019-2024)

• Growth outlook for POC testing for vector-based diseases (VBD) such as dengue and malaria

• Malaria POC testing country spotlight: Malaria testing in malaria via public-private partnerships to drive disease elimination by 2030

• Domestic POC diagnostics players to watch

• Connected blood glucose testing country spotlight: Winning market share in the rise of connected blood glucose testing at Chinese hospitals

Driving growth in the future of POC testing

As APAC moves towards decentralised testing, IVD companies will have to adapt their market strategy to meet the region’s increased demand for affordable POC tests.

Through EIU Healthcare’s team of consultants and IVD Gateway – our proprietary data solution, we support your strategic and tactical business planning and provide answers on the what, where and how to gain market share.